These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1283770)

  • 1. Physical activity and the metabolic cardiovascular syndrome.
    Westheim A; Os I
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S49-53. PubMed ID: 1283770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physical activity and the metabolic syndrome].
    Westheim A; Os I; Hjermann I
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):723-4. PubMed ID: 8465338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American College of Sports Medicine. Position Stand. Physical activity, physical fitness, and hypertension.
    Med Sci Sports Exerc; 1993 Oct; 25(10):i-x. PubMed ID: 8231750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension, insulin resistance, and the metabolic syndrome.
    Natali A; Ferrannini E
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Cléroux J; Feldman RD; Petrella RJ
    CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome X: a review.
    Timar O; Sestier F; Levy E
    Can J Cardiol; 2000 Jun; 16(6):779-89. PubMed ID: 10863169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in hypertension and cardiovascular disease.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):355-67. PubMed ID: 16980199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and lifestyle determinants of the metabolic syndrome.
    Villegas R; Creagh D; Hinchion R; O'Halloran D; Perry IJ
    Ir Med J; 2004; 97(10):300-3. PubMed ID: 15696875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension as a metabolic disorder--an overview.
    Smith U; Gudbjörnsdottir S; Landin K
    J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient.
    Pool JL
    Br J Clin Pract Suppl; 1994 May; 74():8-12. PubMed ID: 8049119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.